Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53
Drug resistance to 5-fluorouracil (5-FU) is still a major limitation to its clinical use. In addition, the clinical value of p53 as a predictive marker for 5-FU-based chemotherapy remains a matter of debate. Here, we used HCTI 16 human colorectal cancer c
Autor principal: | |
---|---|
Outros Autores: | , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2015
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10451/21088 |
País: | Portugal |
Oai: | oai:repositorio.ul.pt:10451/21088 |